Ovarian Cancer Treatment_01 (IMAGE)
Caption
Fabian R. Villagomez, Ph.D., a postdoctoral researcher in the Department of Biological Sciences at The University of Texas at El Paso, is studying high-grade serous carcinoma, an aggressive form of ovarian cancer. His work has helped identify a new target, Claudin-4, that may make the cancer cells more vulnerable to treatment.
Credit
The University of Texas at El Paso.
Usage Restrictions
None
License
Original content